Literature DB >> 36069885

Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post-COVID-19 Conditions.

Siwen Wang1, Luwei Quan2, Jorge E Chavarro1,3,4, Natalie Slopen5, Laura D Kubzansky5, Karestan C Koenen3,5,6, Jae Hee Kang4, Marc G Weisskopf2, Westyn Branch-Elliman7,8, Andrea L Roberts2.   

Abstract

Importance: Few risk factors for long-lasting (≥4 weeks) COVID-19 symptoms have been identified. Objective: To determine whether high levels of psychological distress before SARS-CoV-2 infection, characterized by depression, anxiety, worry, perceived stress, and loneliness, are prospectively associated with increased risk of developing post-COVID-19 conditions (sometimes called long COVID). Design, Setting, and Participants: This prospective cohort study used data from 3 large ongoing, predominantly female cohorts: Nurses' Health Study II, Nurses' Health Study 3, and the Growing Up Today Study. Between April 2020 and November 2021, participants were followed up with periodic surveys. Participants were included if they reported no current or prior SARS-CoV-2 infection at the April 2020 baseline survey when distress was assessed and returned 1 or more follow-up questionnaires. Exposures: Depression, anxiety, worry about COVID-19, perceived stress, and loneliness were measured at study baseline early in the pandemic, before SARS-CoV-2 infection, using validated questionnaires. Main Outcomes and Measures: SARS-CoV-2 infection was self-reported during each of 6 monthly and then quarterly follow-up questionnaires. COVID-19-related symptoms lasting 4 weeks or longer and daily life impairment due to these symptoms were self-reported on the final questionnaire, 1 year after baseline.
Results: Of 54 960 participants, 38.0% (n = 20 902) were active health care workers, and 96.6% (n = 53 107) were female; the mean (SD) age was 57.5 (13.8) years. Six percent (3193 participants) reported a positive SARS-CoV-2 test result during follow-up (1-47 weeks after baseline). Among these, probable depression (risk ratio [RR], 1.32; 95% CI = 1.12-1.55), probable anxiety (RR = 1.42; 95% CI, 1.23-1.65), worry about COVID-19 (RR, 1.37; 95% CI, 1.17-1.61), perceived stress (highest vs lowest quartile: RR, 1.46; 95% CI, 1.18-1.81), and loneliness (RR, 1.32; 95% CI, 1.08-1.61) were each associated with post-COVID-19 conditions (1403 cases) in generalized estimating equation models adjusted for sociodemographic factors, health behaviors, and comorbidities. Participants with 2 or more types of distress prior to infection were at nearly 50% increased risk for post-COVID-19 conditions (RR, 1.49; 95% CI, 1.23-1.80). All types of distress were associated with increased risk of daily life impairment (783 cases) among individuals with post-COVID-19 conditions (RR range, 1.15-1.51). Conclusions and Relevance: The findings of this study suggest that preinfection psychological distress may be a risk factor for post-COVID-19 conditions in individuals with SARS-CoV-2 infection. Future work should examine the biobehavioral mechanism linking psychological distress with persistent postinfection symptoms.

Entities:  

Year:  2022        PMID: 36069885      PMCID: PMC9453634          DOI: 10.1001/jamapsychiatry.2022.2640

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   25.911


  58 in total

Review 1.  Where psychology meets physiology: chronic stress and premature mortality--the Central-Eastern European health paradox.

Authors:  Mária S Kopp; János Réthelyi
Journal:  Brain Res Bull       Date:  2004-02-01       Impact factor: 4.077

2.  Psychological stress, cytokine production, and severity of upper respiratory illness.

Authors:  S Cohen; W J Doyle; D P Skoner
Journal:  Psychosom Med       Date:  1999 Mar-Apr       Impact factor: 4.312

3.  Perceived stress in survivors of suicide: psychometric properties of the Perceived Stress Scale.

Authors:  Ann M Mitchell; Patricia A Crane; Yookyung Kim
Journal:  Res Nurs Health       Date:  2008-12       Impact factor: 2.228

4.  Loneliness during the first half-year of COVID-19 Lockdowns.

Authors:  William D S Killgore; Sara A Cloonan; Emily C Taylor; Daniel A Lucas; Natalie S Dailey
Journal:  Psychiatry Res       Date:  2020-11-04       Impact factor: 3.222

5.  Depression, worry, and loneliness are associated with subsequent risk of hospitalization for COVID-19: a prospective study.

Authors:  Siwen Wang; Luwei Quan; Ming Ding; Jae H Kang; Karestan C Koenen; Laura D Kubzansky; Westyn Branch-Elliman; Jorge E Chavarro; Andrea L Roberts
Journal:  Psychol Med       Date:  2022-05-19       Impact factor: 7.723

Review 6.  Evidence for an immune response in major depression: a review and hypothesis.

Authors:  M Maes
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1995-01       Impact factor: 5.067

7.  SARS-CoV-2 infection in people living with HIV: a systematic review.

Authors:  Paola Costenaro; Chiara Minotti; Elisa Barbieri; Carlo Giaquinto; Daniele Donà
Journal:  Rev Med Virol       Date:  2020-09-01       Impact factor: 6.989

8.  Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women.

Authors:  John P Forman; Gary C Curhan; Eric N Taylor
Journal:  Hypertension       Date:  2008-10-06       Impact factor: 10.190

9.  Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study.

Authors:  Oscar Moreno-Pérez; Esperanza Merino; Jose-Manuel Leon-Ramirez; Mariano Andres; Jose Manuel Ramos; Juan Arenas-Jiménez; Santos Asensio; Rosa Sanchez; Paloma Ruiz-Torregrosa; Irene Galan; Alexander Scholz; Antonio Amo; Pilar González-delaAleja; Vicente Boix; Joan Gil
Journal:  J Infect       Date:  2021-01-12       Impact factor: 6.072

10.  Characterizing long COVID in an international cohort: 7 months of symptoms and their impact.

Authors:  Hannah E Davis; Gina S Assaf; Lisa McCorkell; Hannah Wei; Ryan J Low; Yochai Re'em; Signe Redfield; Jared P Austin; Athena Akrami
Journal:  EClinicalMedicine       Date:  2021-07-15
View more
  1 in total

1.  Change to Open Access Status.

Authors: 
Journal:  JAMA Psychiatry       Date:  2022-09-28       Impact factor: 25.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.